122 related articles for article (PubMed ID: 30388623)
1. miR-125a Promotes the Progression of Giant Cell Tumors of Bone by Stimulating IL-17A and β-Catenin Expression.
Jin H; Li DW; Wang SN; Luo S; Li Q; Huang P; Wang JM; Xu M; Xu CX
Mol Ther Nucleic Acids; 2018 Dec; 13():493-502. PubMed ID: 30388623
[TBL] [Abstract][Full Text] [Related]
2. IL-17A stimulates the progression of giant cell tumors of bone.
Xu M; Song ZG; Xu CX; Rong GH; Fan KX; Chen JY; Zhang W; Jia JP; Han G; Wang W; Chai W; Liang WT; Bi WZ; Wang Y
Clin Cancer Res; 2013 Sep; 19(17):4697-705. PubMed ID: 23857601
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
4. Bilobalide alleviates IL-17-induced inflammatory injury in ATDC5 cells by downregulation of microRNA-125a.
Mao D; Li H; Zhang L; Xu J; Yu C; Zhang Q
J Biochem Mol Toxicol; 2019 Dec; 33(12):e22405. PubMed ID: 31593333
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib Inhibits Giant Cell Tumor of Bone through Induction of Cell Apoptosis and Inhibition of Osteoclast Recruitment, Giant Cell Formation, and Bone Resorption.
Xu L; Luo J; Jin R; Yue Z; Sun P; Yang Z; Yang X; Wan W; Zhang J; Li S; Liu M; Xiao J
Mol Cancer Ther; 2016 May; 15(5):854-65. PubMed ID: 26861247
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone.
Li M; Wang W; Zhu Y; Lu Y; Wan P; Yang K; Zhang Y; Mao C
Acta Biomater; 2018 Sep; 77():365-379. PubMed ID: 30030174
[TBL] [Abstract][Full Text] [Related]
7. miR-125a-5p inhibits the expression of NLRP3 by targeting CCL4 in human vascular smooth muscle cells treated with ox-LDL.
Wang J; Wu Q; Yu J; Cao X; Xu Z
Exp Ther Med; 2019 Sep; 18(3):1645-1652. PubMed ID: 31410121
[TBL] [Abstract][Full Text] [Related]
8. Rs12976445 Polymorphism Is Associated with Post-Ablation Recurrence of Atrial Fibrillation by Modulating the Expression of MicroRNA-125a and Interleukin-6R.
Shen XB; Zhang SH; Li HY; Chi XD; Jiang L; Huang QL; Xu SH
Med Sci Monit; 2018 Sep; 24():6349-6358. PubMed ID: 30203815
[TBL] [Abstract][Full Text] [Related]
9. ALCAM
Zhou Z; Li Y; Wang X; Hu J; Kuang M; Wang Z; Li S; Xu W; Xiao J
Cell Death Dis; 2018 Feb; 9(3):299. PubMed ID: 29463803
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of miR-125a-5p is associated with salivary adenoid cystic carcinoma progression via targeting p38/JNK/ERK signal pathway.
Liang Y; Ye J; Jiao J; Zhang J; Lu Y; Zhang L; Wan D; Duan L; Wu Y; Zhang B
Am J Transl Res; 2017; 9(3):1101-1113. PubMed ID: 28386337
[TBL] [Abstract][Full Text] [Related]
11. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
[TBL] [Abstract][Full Text] [Related]
12. Regulation of IL-6 signaling by miR-125a and let-7e in endothelial cells controls vasculogenic mimicry formation of breast cancer cells.
Park Y; Kim J
BMB Rep; 2019 Mar; 52(3):214-219. PubMed ID: 30670152
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-210 is upregulated by hypoxia-inducible factor-1α in the stromal cells of giant cell tumors of bone.
Guo S; Bai R; Liu W; Zhao A; Zhao Z; Wang Y; Wang Y; Zhao W; Wang W
Mol Med Rep; 2015 Oct; 12(4):6185-92. PubMed ID: 26239498
[TBL] [Abstract][Full Text] [Related]
14. miR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling.
Jin H; Luo S; Wang Y; Liu C; Piao Z; Xu M; Guan W; Li Q; Zou H; Tan QY; Yang ZZ; Wang Y; Wang D; Xu CX
Mol Ther Nucleic Acids; 2017 Sep; 8():111-122. PubMed ID: 28918013
[TBL] [Abstract][Full Text] [Related]
15. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
16. Loss of miR-146b-5p promotes T cell acute lymphoblastic leukemia migration and invasion via the IL-17A pathway.
Tu Z; Xiong J; Xiao R; Shao L; Yang X; Zhou L; Yuan W; Wang M; Yin Q; Wu Y; Pan S; Leng J; Jiang D; He C; Zhang Q
J Cell Biochem; 2019 Apr; 120(4):5936-5948. PubMed ID: 30362152
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone.
Mosakhani N; Pazzaglia L; Benassi MS; Borze I; Quattrini I; Picci P; Knuutila S
Histol Histopathol; 2013 May; 28(5):671-8. PubMed ID: 23172052
[TBL] [Abstract][Full Text] [Related]
18. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
[TBL] [Abstract][Full Text] [Related]
19. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells.
Huang F; Kao CY; Wachi S; Thai P; Ryu J; Wu R
J Immunol; 2007 Nov; 179(10):6504-13. PubMed ID: 17982039
[TBL] [Abstract][Full Text] [Related]
20. miR-125a-3p decreases levels of interlukin-17 and suppresses renal fibrosis via down-regulating TGF-β1 in systemic lupus erythematosus mediated Lupus nephritic mice.
Zhang Y; Chen X; Deng Y
Am J Transl Res; 2019; 11(3):1843-1853. PubMed ID: 30972208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
